Cite
TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells.
MLA
Sun, Xiao, et al. “TLR4 Agonist Activity of Alcaligenes Lipid a Utilizes MyD88 and TRIF Signaling Pathways for Efficient Antigen Presentation and T Cell Differentiation by Dendritic Cells.” International Immunopharmacology, vol. 117, Apr. 2023, p. 109852. EBSCOhost, https://doi.org/10.1016/j.intimp.2023.109852.
APA
Sun, X., Hosomi, K., Shimoyama, A., Yoshii, K., Lan, H., Wang, Y., Yamaura, H., Nagatake, T., Ishii, K. J., Akira, S., Kiyono, H., Fukase, K., & Kunisawa, J. (2023). TLR4 agonist activity of Alcaligenes lipid a utilizes MyD88 and TRIF signaling pathways for efficient antigen presentation and T cell differentiation by dendritic cells. International Immunopharmacology, 117, 109852. https://doi.org/10.1016/j.intimp.2023.109852
Chicago
Sun, Xiao, Koji Hosomi, Atsushi Shimoyama, Ken Yoshii, Huangwenxian Lan, Yunru Wang, Haruki Yamaura, et al. 2023. “TLR4 Agonist Activity of Alcaligenes Lipid a Utilizes MyD88 and TRIF Signaling Pathways for Efficient Antigen Presentation and T Cell Differentiation by Dendritic Cells.” International Immunopharmacology 117 (April): 109852. doi:10.1016/j.intimp.2023.109852.